Last reviewed · How we verify

NCT03717116

Early Prediction of Hypocalcemia After Thyroidectomy Using Postoperative Second Hour Parathormone

Status unknown Last updated 24 October 2018
What this trial tests

trial testing parathormone level in Hypocalcemia, Postoperative Parathormone in 110 participants. Status unknown.

Timeline
1 September 2017
Primary endpoint
31 October 2018
1 December 2018

Quick facts

Lead sponsorIstanbul University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment110
Start date1 September 2017
Primary completion31 October 2018
Estimated completion1 December 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 20 to 80, any sex, with Hypocalcemia, Postoperative Parathormone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypocalcemia is the most frequent complication in thyroid surgeries. Diagnosing this complication earlier will reduce longer hospital stay and will lead to an earlier intervention. The purpose of the study is to evaluate postoperative second hour parathyroid hormone measurement as a predictor for early stage hypocalcemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03717116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing